DE69724438D1 - Nicht peptidische g-csf mimetika - Google Patents

Nicht peptidische g-csf mimetika

Info

Publication number
DE69724438D1
DE69724438D1 DE69724438T DE69724438T DE69724438D1 DE 69724438 D1 DE69724438 D1 DE 69724438D1 DE 69724438 T DE69724438 T DE 69724438T DE 69724438 T DE69724438 T DE 69724438T DE 69724438 D1 DE69724438 D1 DE 69724438D1
Authority
DE
Germany
Prior art keywords
pct
compounds
peptidic
date nov
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69724438T
Other languages
English (en)
Other versions
DE69724438T2 (de
Inventor
I Luengo
A Chan
L Breen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE69724438D1 publication Critical patent/DE69724438D1/de
Publication of DE69724438T2 publication Critical patent/DE69724438T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69724438T 1996-05-22 1997-05-22 Nicht peptidische g-csf mimetika Expired - Lifetime DE69724438T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1954296P 1996-05-22 1996-05-22
US19542P 1996-05-22
PCT/US1997/008864 WO1997044033A1 (en) 1996-05-22 1997-05-22 Non-peptide g-csf mimetics

Publications (2)

Publication Number Publication Date
DE69724438D1 true DE69724438D1 (de) 2003-10-02
DE69724438T2 DE69724438T2 (de) 2004-06-09

Family

ID=21793762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69724438T Expired - Lifetime DE69724438T2 (de) 1996-05-22 1997-05-22 Nicht peptidische g-csf mimetika

Country Status (17)

Country Link
US (1) US5981551A (de)
EP (1) EP0920314B1 (de)
JP (1) JP2000512629A (de)
KR (1) KR20000015881A (de)
AT (1) ATE247959T1 (de)
AU (1) AU722453B2 (de)
BR (1) BR9709326A (de)
CA (1) CA2255731A1 (de)
CZ (1) CZ376798A3 (de)
DE (1) DE69724438T2 (de)
ES (1) ES2205239T3 (de)
IL (1) IL127065A0 (de)
NO (1) NO985406D0 (de)
NZ (1) NZ332823A (de)
PL (1) PL330148A1 (de)
TR (1) TR199802401T2 (de)
WO (1) WO1997044033A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US20010016568A1 (en) 1997-10-31 2001-08-23 Juan I. Luengo Novel metal complexes
DE69839191T2 (de) * 1997-10-31 2009-02-19 Smithkline Beecham Corp. Metall-komplexe mit antibakteriele und fungizide wirkungen
EP1071667A4 (de) * 1998-04-14 2004-10-20 Smithkline Beecham Corp Receptorliganden
TWI242563B (en) * 1998-04-30 2005-11-01 Tanox Inc Monoclonal agonist antibodies which specifically bind to or interact with human G-CSF receptor
US6630470B1 (en) * 1998-05-22 2003-10-07 Smithkline Beecham Corporation G-CSF mimetics
JP2002516329A (ja) * 1998-05-22 2002-06-04 スミスクライン・ビーチャム・コーポレイション Ｇ−ｃｓｆ模倣物
JP2002167378A (ja) 2000-09-22 2002-06-11 Ss Pharmaceut Co Ltd イミダゾール誘導体又はその塩
US20050084908A1 (en) * 2000-11-06 2005-04-21 Chugai Seiyaku Kabushiki Kaisha Methods for detecting binding of low-molecular-weight compound and its binding partner molecule
US7084070B1 (en) 2001-03-30 2006-08-01 Lam Research Corporation Treatment for corrosion in substrate processing
US20020177321A1 (en) * 2001-03-30 2002-11-28 Li Si Yi Plasma etching of silicon carbide
CA2472711C (en) 2002-01-18 2012-03-20 Yamanouchi Pharmaceutical Co., Ltd. 2-acylaminothiazole derivative or salt thereof
JP2006347882A (ja) * 2003-09-02 2006-12-28 Ss Pharmaceut Co Ltd ベンジルアルコール誘導体又はその塩
US8338373B2 (en) * 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
US20090226397A1 (en) 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
ES2405506T3 (es) 2003-10-24 2013-05-31 Nora Therapeutics, Inc. Un método para obtener datos útiles en la identificación de un paciente con riesgo de tener dificultad de llevar a término un embarazo
CN102223893B (zh) 2008-07-22 2014-07-16 曼诺吉尼克斯公司 治疗与绝经、激素改变和关节炎相关的症状的组合物和方法
US9151289B2 (en) 2008-08-21 2015-10-06 Cummins Inc. Fuel pump
CZ302068B6 (cs) * 2009-07-28 2010-09-22 Univerzita Pardubice Zpusob prípravy cis-1,3,4,6-tetranitrooktahydroimidazo-[4,5-d]imidazolu
WO2015057724A1 (en) 2013-10-14 2015-04-23 Nora Therapeutics, Inc. Use of g-csf for treating or preventing villitis of unknown etiology in a human female

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2596126A (en) * 1943-02-24 1952-05-13 Homer W Carhart Method for separating diaryl-2-imino hydantoins from the corresponding 2,5-di-imino glycolurils
JPS4995992A (de) * 1973-01-27 1974-09-11
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor

Also Published As

Publication number Publication date
EP0920314B1 (de) 2003-08-27
AU722453B2 (en) 2000-08-03
KR20000015881A (ko) 2000-03-15
IL127065A0 (en) 1999-09-22
US5981551A (en) 1999-11-09
NO985406L (no) 1998-11-20
CZ376798A3 (cs) 1999-04-14
ES2205239T3 (es) 2004-05-01
WO1997044033A1 (en) 1997-11-27
CA2255731A1 (en) 1997-11-27
EP0920314A4 (de) 2001-08-16
ATE247959T1 (de) 2003-09-15
DE69724438T2 (de) 2004-06-09
AU3286597A (en) 1997-12-09
BR9709326A (pt) 1999-08-10
EP0920314A1 (de) 1999-06-09
PL330148A1 (en) 1999-04-26
JP2000512629A (ja) 2000-09-26
NO985406D0 (no) 1998-11-20
TR199802401T2 (xx) 1999-03-22
NZ332823A (en) 2000-05-26

Similar Documents

Publication Publication Date Title
DE69724438D1 (de) Nicht peptidische g-csf mimetika
NZ290420A (en) Phenyl or pyridyl-amide substituted dihydro benzofurans; medicaments
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
DE69622031D1 (de) INDOLDERIVATE ALS cGMP-PDE INHIBITOREN
CA2297911A1 (en) Substituted 6-phenylphenanthridines
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
ZA918331B (en) Antimicrobial agents as well as substituted 2-cyclohexan-1-yl-amine derivatives and their preparation
IL133824A (en) Tetrazole derivatives and medicaments containing the same
IL136359A (en) Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
AP9801377A0 (en) Tricyclic erythromycin derivatives.
AU1366802A (en) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
IL114968A (en) 1,4-dihydropyridine compounds and pharmaceutical compositions containing them
SE9504662D0 (sv) New compounds
AU3928695A (en) Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof
AU758194C (en) Novel benzimidazoles and benzoxazoles